参考文献/References:
[1] 中国特发性正常压力脑积水诊治专家共识[J]. 中华医学杂志，2016，96（21）：1635-1638.
[2] 詹潮鸿，张向阳，肖格磊. 脑积水发病机制的研究进展[J]. 中南大学学报（医学版），2019，44（10）：188-1195.
[3] Karimy JK, Reeves BC, Damisah E, et al. Inflammation in acquired hydrocephalus: pathogenic mechanisms and therapeutic targets [J]. Nat Rev Neurol, 2020, 16(5): 285-296.
[4] Reeves BC, Karimy JK, Kundishora AJ, et al. Glymphatic system impairment in Alzheimer’s disease and idiopathic normal pressure hydrocephalus [J]. Trends Mol Med, 2020,26(3): 285-295.
[5] Karimy JK, Zhang J, Kurland DB, et al. Inflammation-dependent cerebrospinal fluid hypersecretion by the choroidplexus epithelium in posthemorrhagic hydrocephalus [J]. Nat Med, 2017, 23(8): 997-1003.
[6] Filippidis A, Carozza R, Rekate H. Aquaporins in brainedema and neuropathological conditions [J]. Int J Mol Sci,2017, 18(1): 55.
[7] Desai B, Hsu Y, Schneller B, et al. Hydrocephalus: the role of cerebral aquaporin-4 channels and computational mo-deling considerations of cerebrospinal fluid [J]. Neurosurg Focus, 2016, 41(3): E8.
[8] Mestre H, Tithof J, Du T, et al. Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension[J]. Nat Commun, 2018, 9(1): 4878.
[9] Laviv Y, Kasper BS, Kasper EM. Vascular hyperpermeabili-ty as a hallmark of phacomatoses: is the etiology angiogene-sis comparable with mechanisms seen in inflammatory pathways? Part I: historical observations and clinical per-spectives on the etiology of increased CSF protein levels, CSF clotting, and communicating hydrocephalus: a compre-hensive review [J]. Neurosurg Rev, 2018, 41(4): 957-968.
[10] Oliveira LM, Nitrini R, Román GC. Normal-pressure hydro-cephalus: a critical review [J]. Dement Neuropsychol, 2019,13(2): 133-143.
[11] Ringstad G, Vatnehol SAS, Eide PK. Glymphatic MRI inidiopathic normal pressure hydrocephalus [J]. Brain, 2017,140(10): 2691-2705.
[12] Krishnamurthy S, Tichenor MD, Satish AG, et al. A pro-posed role for efflux transporters in the pathogenesis of hydrocephalus [J]. Croat Med J, 2014, 55(4): 366-376.
[13] Shim JW, Sandlund J, Hameed MQ, et al. Excess HB-EGF, which promotes VEGF signaling, leads to hydrocephalus [J]. Sci Rep, 2016, 6(1): 26794.
[14] Wang Z, Zhang Y, Hu F, et al. Pathogenesis and pathophy-siology of idiopathic normal pressure hydrocephalus [J]. CNS Neurosci Ther, 2020, 26(12): 1230-1240.
[15] Bateman GA, Siddique SH. Cerebrospinal fluid absorption block at the vertex in chronic hydrocephalus: obstructed arachnoid granulations or elevated venous pressure [J]. Fluids Barriers CNS, 2014, 11: 11.
[16] Jacobsson J, Qvarlander S, Eklund A, et al. Comparison of the CSF dynamics between patients with idiopathic normal pressure hydrocephalus and healthy volunteers [J]. J Neuro-surg, 2018, 131: 1018-1023.
[17] Satow T, Aso T, Nishida S, et al. Alteration of venous drain-age route in idiopathic normal pressure hydrocephalus and normal aging [J]. Front Aging Neurosci, 2017, 9: 387.
[18] Román GC, Jackson RE, Fung SH, et al. Sleep-disordered breathing and idiopathic normal-pressure hydrocephalus: recent pathophysiological advances [J]. Curr Neurol Neuro-sci Rep, 2019, 19(7): 39.
[19] Ringstad G, Valnes LM, Dale AM, et al. Brain-wide glym-phatic enhancement and clearance in humans assessed with MRI [J]. JCI Insight, 2018, 3(13): e121537.
[20] Ding Y, Zhang T, Wu G, et al. Astrogliosis inhibition attenu-ates hydrocephalus by increasing cerebrospinal fluid reabsorption through the glymphatic system after germinal matrix hemorrhage [J]. Exp Neurol, 2019, 320: 113003.
[21] Ma Q, Ineichen BV, Detmar M, et al. Outflow of cerebrospi-nal fluid is predominantly through lymphatic vessels and is reduced in aged mice [J]. Nat Commun, 2017, 8(1): 1434.
[22] Eide PK, Valnes LM, Pripp AH, et al. Delayed clearance of cerebrospinal fluid tracer from choroid plexus in idiopathic normal pressure hydrocephalus [J]. J Cereb Blood Flow Metab, 2020, 40(9): 1849-1858.
[23] Bothwell SW, Janigro D, Patabendige A. Cerebrospinal fluid dynamics and intracranial pressure elevation in neurologi-cal diseases [J]. Fluids Barriers CNS, 2019, 16(1): 9.
相似文献/References:
[1]杜彦挺 综述 潘亚文 审校.Moyamoya病的诊断和治疗的研究进展[J].中国临床神经外科杂志,2015,(12):761.[doi:10.13798/j.issn.1009-153X.2015.12.021]
[2]陈 娟 张华楸 综述 雷 霆 审校.库欣病发病机制的研究进展[J].中国临床神经外科杂志,2015,(10):594.[doi:10.13798/j.issn.1009-153X.2015.10.006]
[3]王米君 综述 舒 凯 审校.脑膜瘤瘤周水肿的研究现状[J].中国临床神经外科杂志,2015,(05):315.[doi:10.13798/j.issn.1009-153X.2015.05.022]
[4]管得宁,张 扬,徐 运.帕金森病的发病机制及治疗研究进展[J].中国临床神经外科杂志,2016,(11):732.[doi:10.13798/j.issn.1009-153X.2016.11.031]
[5]陆丽娟,李玉凤,赵喜庆 综述,等.氯离子通道与胶质瘤的关系研究进展[J].中国临床神经外科杂志,2016,(12):803.[doi:10.13798/j.issn.1009-153X.2016.12.029]
[6]吴 超 于 涛 王振宇 段丽萍.脊髓损伤后神经源性肠功能障碍的发生机制[J].中国临床神经外科杂志,2017,(04):282.[doi:10.13798/j.issn.1009-153X.2017.04.030]
[7]吕艳霞 李安荣 杨朋磊 综述 胡钧涛 审校.炎症反应在颅内动脉瘤发生中作用的研究进展[J].中国临床神经外科杂志,2017,(05):363.[doi:10.13798/j.issn.1009-153X.2017.05.030]
[8]马 涛.颅脑损伤后凝血功能障碍的机制及干预措施[J].中国临床神经外科杂志,2017,(08):601.[doi:10.13798/j.issn.1009-153X.2017.08.030]
[9]田 杨 综述,史怀璋 审校.非编码RNA参与颅内动脉瘤病理机制的研究进展[J].中国临床神经外科杂志,2018,(10):701.[doi:10.13798/j.issn.1009-153X.2018.10.021]
[10]曾子桓 张 灏 陈伟强 魏梁锋 王守森.颅脑损伤后继发性脑损伤发病机制的研究进展[J].中国临床神经外科杂志,2019,(12):777.[doi:10.13798/j.issn.1009-153X.2019.12.022]